Metabotropic gaba receptor complex issued from the central nervous system
CA 2343574 A1 · Owner: Basf-Lynx Bioscience Ag · Inventors: Hirschfeld, Kirsten; Kuner, Rohini; Kornau, Hans-Christian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to isolated proteins which code for metabotropic GABA receptors and which, together with GABAB receptor proteins form a , metabotropic GABA receptor complex (= protein heteromer). The invention also relates to nucleic acid sequences or recombinant nucleic acid constructs which code for the proteins. In addition, the invention relates to host organisms or transgenic animals containing the nucleic acid sequences or the recombinant nucleic acid constructs and to monoclonal or polyclonal antibodies which are directed against the isolated proteins. The invention also relates to a method for locating substances with a specific affinity to binding to the inventive …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 11, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 11, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 11, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.